LDX 0.00% 4.5¢ lumos diagnostics holdings limited

Ann: Investor Briefing on new Hologic Agreements, page-16

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,298 Posts.
    lightbulb Created with Sketch. 169


    Further reading into Hologic and the products available, I have a feeling Lumos is upgrading a new assay ready for Hologic to either replace or improve an existing assay reader:

    https://hotcopper.com.au/data/attachments/5886/5886394-eaa76e4ae9c12579016c3b5dd7cb7083.jpg

    The above is the Hologic TLiIQ® Rapid fFN diagnostic assay reader.

    What is it designed to do? fFN is an adhesive glycoprotein found at the maternal-fetal interface which functions like a glue to bind the baby to the uterus during fetal development.1 fFN is generally absent in vaginal secretions during weeks 16 to 35 of gestation, so if fetal fibronectin is detectable in vaginal discharge during pregnancy weeks 22-35, it means that the protein is “leaking.” This can alert healthcare providers that the patient is at risk of preterm birth.

    https://hotcopper.com.au/data/attachments/5886/5886431-32a5a6d2881bcdfeaa9cd2e4b35d1078.jpg
    https://hotcopper.com.au/data/attachments/5886/5886434-a2374509e16e3421af647959bd8fd4fd.jpg

    https://hotcopper.com.au/data/attachments/5886/5886438-287060bf20c769a0724ef011e2add488.jpg
    This product has not been released/announced by Lumos to date. Unless someone can find it in an announcement i cant see?
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.